tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Alnylam Pharmaceuticals Inc

ALNY
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
206.380USD
-80.240-28.00%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย ๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
27.32B์‹œ๊ฐ€์ด์•ก
50.51P/E TTM

Alnylam Pharmaceuticals Inc

206.380
-80.240-28.00%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

ALNY ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Alnylam Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
Jul 30, 2026
EPS / ์˜ˆ์ƒ
--/1.55
์ˆ˜์ต / ์˜ˆ์ƒ
--/1.32B
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
3.71B
65.19%
EPS(YoY)
2.39
209.91%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/30
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
342.66%1.23
449.70%1.55
317.31%1.41
320.15%1.91
-280.74%-0.51
15.20%-0.44
40.89%-0.65
-173.53%-0.87
93.98%-0.13
62.74%-0.52
34.79%-1.10
--1.18
---2.21
---1.40
---1.68
---7.62
----
----
----
----
์ˆ˜์ต
51.50%1.17B
96.43%1.17B
84.95%1.10B
149.35%1.25B
17.26%773.69M
20.20%594.19M
34.90%593.17M
-33.26%500.92M
107.00%659.83M
54.82%494.33M
31.25%439.72M
183.96%750.53M
41.78%318.75M
49.72%319.29M
29.59%335.04M
40.86%264.31M
1.93%224.82M
20.10%213.26M
58.07%258.54M
49.09%187.63M
์ˆœ์ด์ต
348.19%164.49M
458.38%205.99M
322.56%186.42M
325.05%251.08M
-292.43%-66.28M
12.82%-57.48M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
33.55%-137.87M
136.40%147.75M
0.50%-276.02M
27.56%-174.10M
19.72%-207.49M
-98.48%-405.92M
-46.34%-277.40M
-20.00%-240.34M
-6.13%-258.46M
19.26%-204.51M
์ˆœ์ด์ต๋ฅ 
263.83%14.03%
282.44%17.65%
220.34%16.99%
190.25%20.10%
-234.67%-8.57%
27.47%-9.67%
54.96%-14.12%
-213.14%-22.27%
97.04%-2.56%
75.54%-13.34%
49.37%-31.35%
--19.69%
---86.59%
---54.53%
---61.93%
---131.50%
----
----
----
----
์ด ์ด์ต๋ฅ 
-8.57%74.54%
-6.97%81.91%
-8.55%75.60%
1.36%83.98%
-9.01%81.52%
1.60%88.04%
2.72%82.67%
-6.66%82.85%
22.36%89.59%
4.63%86.65%
-4.99%80.47%
--88.77%
--73.22%
--82.82%
--84.70%
--83.26%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
118.54%49.13%
116.79%52.76%
124.82%54.33%
112.11%51.63%
-11.86%22.48%
-8.90%24.34%
-9.33%24.17%
-8.36%24.34%
-14.82%25.51%
-10.97%26.72%
-7.05%26.65%
--26.56%
--29.94%
--30.01%
--28.68%
--28.74%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
51.50%1.17B
96.43%1.17B
84.95%1.10B
149.35%1.25B
17.26%773.69M
20.20%594.19M
34.90%593.17M
-33.26%500.92M
107.00%659.83M
54.82%494.33M
31.25%439.72M
183.96%750.53M
41.78%318.75M
49.72%319.29M
29.59%335.04M
40.86%264.31M
1.93%224.82M
20.10%213.26M
58.07%258.54M
49.09%187.63M
์˜์—… ์ด์ต
795.12%112.60M
1386.07%268.64M
225.26%131.72M
578.49%367.98M
-133.32%-16.20M
141.62%18.08M
9.66%-105.16M
-135.96%-76.91M
121.15%48.61M
71.01%-43.44M
38.28%-116.40M
182.88%213.87M
-19.90%-229.83M
-2.10%-149.81M
3.06%-188.61M
-42.03%-258.04M
-31.15%-191.69M
21.22%-146.73M
-0.17%-194.56M
19.33%-181.68M
์ˆœ์ด์ต
348.19%164.49M
458.38%205.99M
322.56%186.42M
325.05%251.08M
-292.43%-66.28M
12.82%-57.48M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
33.55%-137.87M
136.40%147.75M
0.50%-276.02M
27.56%-174.10M
19.72%-207.49M
-98.48%-405.92M
-46.34%-277.40M
-20.00%-240.34M
-6.13%-258.46M
19.26%-204.51M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
26.80%4.62B
29.10%4.22B
22.92%4.05B
17.80%3.95B
14.84%3.64B
9.36%3.27B
10.48%3.30B
12.39%3.36B
25.71%3.17B
17.61%2.99B
10.79%2.98B
10.95%2.99B
2.12%2.52B
-1.88%2.54B
-4.14%2.69B
0.58%2.69B
-9.30%2.47B
4.84%2.59B
7.41%2.81B
4.72%2.68B
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
16.27%1.51B
25.46%1.35B
23.61%1.47B
27.43%1.56B
23.27%1.30B
14.22%1.08B
22.58%1.19B
28.52%1.22B
33.81%1.06B
39.85%941.71M
26.03%967.79M
22.90%949.78M
19.91%788.64M
11.13%673.39M
10.38%767.91M
26.55%772.79M
18.58%657.68M
22.46%605.96M
18.87%695.71M
27.16%610.66M
์ด ์ž์‚ฐ
21.74%5.56B
21.73%5.13B
17.13%4.97B
15.38%4.85B
13.88%4.57B
10.18%4.21B
10.71%4.24B
9.53%4.21B
17.85%4.01B
12.75%3.82B
7.99%3.83B
8.59%3.84B
2.16%3.40B
-1.21%3.39B
-2.66%3.55B
1.81%3.54B
-5.10%3.33B
5.48%3.43B
6.93%3.64B
4.99%3.47B
๋ถ€์ฑ„ ์ด๊ณ„
-2.57%4.20B
-1.08%4.05B
0.10%4.18B
10.67%4.62B
7.54%4.32B
1.35%4.10B
3.02%4.17B
4.19%4.17B
5.31%4.01B
10.75%4.04B
9.34%4.05B
11.16%4.00B
20.80%3.81B
20.41%3.65B
21.26%3.70B
32.63%3.60B
18.76%3.15B
30.20%3.03B
27.78%3.06B
29.83%2.72B
์ž๋ณธ ์ด๊ณ„
440.37%1.35B
831.59%1.08B
1076.33%789.18M
622.92%233.89M
8270.56%250.59M
152.64%115.44M
130.41%67.09M
119.51%32.35M
99.25%-3.07M
15.42%-219.27M
-39.45%-220.64M
-145.23%-165.87M
-331.84%-408.13M
-164.62%-259.24M
-126.90%-158.22M
-108.95%-67.64M
-79.37%176.04M
-56.69%401.17M
-42.12%588.20M
-37.79%755.89M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
112.53%326.72M
159.59%70.50M
272.78%163.56M
643.84%325.11M
23.82%153.73M
-45.14%-118.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
77.42%-29.80M
411.76%359.41M
51.97%-58.99M
2.76%-166.47M
12.10%-131.98M
13.99%-115.28M
-0.79%-122.82M
27.36%-171.19M
-21.92%-150.14M
-21.49%-134.04M
์ˆœํˆฌ์ž
-157.08%-363.46M
-122.45%-25.54M
29.76%-37.17M
1756.55%501.11M
-516.56%-141.38M
268.25%113.77M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-72.01%-240.66M
-103.43%-10.76M
-106.10%-8.71M
48.30%-76.22M
66.16%-139.91M
455.60%313.89M
-9.06%142.79M
-306.61%-147.42M
-322.32%-413.40M
-775.01%-88.27M
์ˆœ์žฌ๋ฌดํ™œ๋™
-32.59%36.24M
-64.35%15.71M
46.20%45.32M
-536.33%-448.35M
-59.12%53.76M
52.48%44.08M
-20.98%31.00M
210.08%102.75M
146.27%131.50M
-37.65%28.91M
-38.16%39.23M
-88.84%33.14M
76.00%53.39M
32.66%46.37M
-78.30%63.44M
-48.24%297.02M
-90.80%30.34M
-31.70%34.96M
34.11%292.29M
1580.50%573.84M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Alnylam Pharmaceuticals Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 3.71B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.25B์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 4.05B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.92์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Alnylam Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 4.97B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 17.13์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Alnylam Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 4.18B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 0.10์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Alnylam Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 789.18M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1076.33์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Alnylam Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ 501.58M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 383.56์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Alnylam Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” 436.33M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 473.44์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Alnylam Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ -305.19M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -203.75์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ 2.39์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 209.91์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 313.75M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 212.79์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 8.45์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 168.28์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 81.64์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -4.64์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 54.33์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.81์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 6.82์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 198.87์ž…๋‹ˆ๋‹ค.

Alnylam Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Alnylam Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ 501.58M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 383.56์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ